Scimitar bean

Scimitar Bean (Canavalia gladiata): A Comprehensive Reference

1. Identity and Botanical Overview

Scientific Nomenclature and Taxonomy

Canavalia gladiata, the sword bean or scimitar bean, is a domesticated plant species in the legume family Fabaceae. Sword beans were originally described as Dolichos gladiatus by Jacquin in 1788. In 1825, Augustin-Pyrame de Candolle published the species as Canavalia gladiata (Jacq.) DC., which is the scientific name currently used for sword bean. The basionym Dolichos gladiatus Jacq. is its principal synonym, alongside a range of older names including Canavalia machaeroides, Canavalia incurva, and Malocchia gladiata, all now treated as synonymous with the accepted species.

Common Names and Linguistic Variants

In English the plant is known as sword bean, jack bean, scimitar bean, and Jamaican horse bean; in Hindi as Khadsampal and Badi sem; in Manipuri as Tebi; and in Tamil as Segapputa. In Chinese it is called Dao dou; in Danish Sabelbønne; in Dutch Zwaardboon; in French Haricot sabre, Pois sabre, or Dolique sabre; in German Schwertbohne; and in Japanese Nata mame (鉈豆). In Sanskrit the plant is recorded as Asphotah and Mahasimbi; in Telugu as Tamma; in Kannada as Halasande; in Malayalam as Valamara; in Marathi as Abai; and in Bengali as Makhan Sim.

Morphology

Sword beans are a climbing, herbaceous vine that can reach lengths of up to 10 meters (33 ft) under optimal conditions. The inflorescence is a raceme bearing 10 to 20 flowers, which are either white or light purple; each flower measures approximately 3 cm (1.2 in) in length. The fruits are shaped as long, straight, slightly compressed pods, measuring 20–40 cm (8–16 in), up to 60 cm (24 in) with a rough surface. Each pod contains 8 to 16 seeds, which are oblong-ellipsoid and variable in color, ranging from red and red-brown to white or black.

Distinction from Related Species

Common names like "sword bean" and "scimitar bean" are widely used but occasionally cause taxonomic confusion with the closely related Canavalia ensiformis (jack bean), due to overlapping morphology and uses, though the two species differ in pod shape and native distributions. The two species are very close, and while they have always been distinguished in Floras, genetic assessment has failed to show clear differences between them.

Origin, Distribution, and Cultivation

Canavalia gladiata is believed to have come from the Old World, probably in eastern Asia, where domestication likely started. Still today, sword beans are widely distributed in those regions and are most commonly cultivated in the south, southeast, and east Asia; the plant is also common in Saudi Arabia, East Africa, South Africa, and Madagascar. Sword beans can be found from sea level up to 900 m elevation and need temperatures between 20 and 30°C (68 and 86°F) with about 900–1,500 mm of evenly distributed rainfall per year.

2. Traditional and Historical Use

Traditional Chinese Medicine (TCM)

Canavalia gladiata is a significant traditional Chinese medicine that has been used to treat hiccups, vomiting, nausea, amenorrhea, chronic dysentery, larynx arthralgia, lumbago, and inflammatory diseases in Asia for a long history. The plant has significant ethnobotanical value and is referred to as Dao Dou in Traditional Chinese Medicine (TCM). In traditional Chinese medicine, the material is described in the Chinese Materia Medica and pharmacopoeias as a water-based decoction taken for digestive and respiratory complaints. The traditional method of preparation involves harvesting the mature fruits, stripping the seeds, drying them, and crushing before use.

Korean and Japanese Traditional Medicine

Multiple countries have used sword beans in their traditional medicine. In Korea, it is thought to help with many ailments such as vomiting, abdominal dropsy, kidney-related lumbago, asthma, obesity, and stomach-ache. In Korea it is also used in the treatment of dysentery, coughs, headache, intercostal neuralgia, epilepsy, schizophrenia, inflammatory diseases, and swellings. In Japan, sword bean is traditionally considered effective in treating ozena, haemorrhoids, pyorrhoea, otitis media, boils, cancers, all kinds of inflammatory diseases, and atopic dermatitis. A soap made with red sword bean extract is marketed in Korea for treating athlete's foot and acne.

Indian Subcontinent and Ayurveda

The plant is used as a vegetable in interior central and south central India, though not commercially farmed, and the unripe pods are eaten as a vegetable in Africa and Asia. In parts of southern India, women traditionally boil the mature seeds in water after thorough soaking to reduce bitterness, and use the liquid to ease colic and flatulence. In the Ayurvedic system, the plant is described as hot in potency (Virya), aphrodisiac (Vrishya), heavy to digest (Guru), and as something that reduces digestive strength (Agnisada); it is said to balance Vata dosha while increasing Kapha and Pitta doshas.

African, Southeast Asian, and Other Traditional Uses

Both sword bean (C. gladiata) and jack bean (C. ensiformis) are used in Nigeria as ornamental plants, and in some places they are believed to be "snake repellents." In Madagascar, the young green fruits and immature seeds of sword bean are used as a cooked vegetable. In Southeast Asian countries such as Indonesia and Sri Lanka, young pods are sliced and added to soups, stews, or vegetable stir-fries, often replacing broader beans in traditional recipes. In Korea and Japan, the seeds and pods of C. gladiata have been used as a coffee substitute.

Traditional Food Processing Preparations

Multiple methods were developed to deal with the antinutritive components of sword beans. Young leaves, flowers, tender green pods and seeds are edible after cooking; young pods are sliced and cooked or eaten raw; young seeds are edible after cooking, and the mature seeds are as well, but only after prolonged cooking. In Japan, the young, tender pods are processed into several kinds of pickles called "Fukujin-zuke," "Nuka-zuke," and "Miso-zuke." In Java, the de-skinned and twice-boiled seeds are left in running water for 2 days, allowed to ferment for 3–4 days, and cooked before being eaten as flavoring; after steaming, young leaves and flowers are also used as flavoring. In Cuba, seeds are used as a substitute for coffee.

3. Key Chemical Constituents and Active Compounds

Overall Phytochemical Complexity

Based on reported information, more than 231 components have been identified in C. gladiata, including flavonoids, terpenes, steroids, organic acids, nitrogenous compounds, amino acids, and proteins. Phytochemical screening consistently shows a high concentration of polar secondary metabolites, especially concentrated in seed extracts of methanol and ethyl acetate. Phenolic chemicals, flavonoids, tannins, saponins, and several glycosides (including cardiac glycosides) are among the main components described.

Canavanine

A non-protein amino acid, canavanine, is present in the mature seeds and is considered the predominant amino acid, showing specific toxic and antitumor activity. Structurally, canavanine is a non-protein amino acid analog of arginine and is a potent antimicrobial and antiviral agent, but can be toxic if ingested in large quantities, interfering with cellular metabolism. Ripe seeds contain antinutritional substances including canavanine, urease, concanavalin A and B, and canavalin.

Lectins: Concanavalin A and Related Proteins

Lectins — proteins or glycoproteins that bind reversibly to specific monosaccharides or oligosaccharides — are widely distributed in legume seeds, and the seeds of the genus Canavalia (including C. gladiata) show the presence of lectins, with their contents and extractability at different pH exhibiting some differences. The lectin of red sword bean (RSB) shows specificity to mannose, glucose, maltose, methyl-d-mannoside, and thyroglobulin. RSB lectin exhibits similarities to Concanavalin A in amino acid composition and sequence, shows mitogenic activity for mouse splenic cells, strong antiproliferative activity for B16 melanoma cells, and also enhances the activity of splenic natural killer (NK) cells against YAC-1 cells; thus RSB lectin has the potential to be used as a bioactive protein in medical research.

Gallotannins and Phenolic Acids

Red sword bean coats are excellent natural sources of gallotannins, and their gallotannin-rich extracts can be utilized as natural antioxidant and antibacterial agents. Gallic acid (4.02 mg/g) has been identified as the main component of C. gladiata extract via LC-MS/MS and HPLC analysis. This non-flavonoid tannin is known for its anti-inflammatory, anti-cancer, liver protection, vascular disease prevention, and strong antioxidant functions.

Flavonoids and Unique Phytochemicals

The plant contains a number of phytochemicals such as alkaloids, canavalin, concanavalin A and B, flavonoids, terpenoids, saponins, gallotannins, and is an excellent natural source of proteins. Gladiatin, a new 5-deoxyflavonol, has been isolated from Canavalia gladiata (Chem. Nat. Compd., 2014). In a separate study on medicinal foodstuffs, researchers isolated canavalioside (a new ent-kaurane-type diterpene glycoside) and gladiatosides A1, A2, A3, B1, B2, B3, C1, and C2 (new acylated flavonol glycosides) from the seeds of Canavalia gladiata, published in Chem. Pharm. Bull. (2000), 48(11):1673–1680.

Other Notable Constituents

The plant contains several bioactive components such as canavanine, gibberellin I, and gibberellin II, which are known to have antioxidant, antibacterial, and antidiabetic properties. Urease extracted from the seeds is also used to detect urea in human blood, underscoring its biochemical significance beyond nutrition. 4-O-methylgallic acid has been isolated from the seed of Canavalia gladiata and identified as a compound with potential as an antiangiogenic agent (Biochemical and Biophysical Research Communications, 2005, vol. 330, issue 4, pages 1268–1274).

Amino Acid Profile

Several studies have highlighted the predominance of leucine as the essential amino acid, and aspartic acid and glutamic acid as the non-essential amino acids in seeds. The seed coats of C. gladiata are often red, white, and black; due to their high phenolic content, the red and black seeds exhibit greater antioxidant potential compared to the white seeds.

4. Scientific Evidence by Area of Use

4.1 Anti-Inflammatory Activity

C. gladiata has been demonstrated to have anti-inflammatory properties using several in vitro assays, including egg albumin denaturation, heat-induced and hypotonicity-induced red blood cell (RBC) membrane stabilization, and hyaluronidase (HAase) inhibitory activity methods.

A key preclinical study investigated the molecular mechanisms underlying this anti-inflammatory action in both cell-based and animal models. Sword bean pod (SBP) extract reduced nitric oxide production and decreased mRNA and protein expression of inflammatory mediators (inducible nitric oxide synthase [iNOS] and cyclooxygenase-2 [COX-2]), and inhibited the phosphorylation of nuclear factor kappa B (NF-κB), a major signaling molecule in the inflammatory response. Additionally, SBP extract treatment inhibited PI3K/mTOR signaling activity to further inhibit degranulation and allergy mediator generation, and controlled the balance of Th1/Th2 cells; the SBP extract exhibited anti-allergic effects in anti-dinitrophenyl IgE-induced RBL-2H3 cells and ovalbumin-treated mice.

C. gladiata exhibits strong antioxidant properties, and ethanol extracts have demonstrated anti-inflammatory effects in dextran sulfate sodium (DSS)-induced colitis models.

Evidence strength: Evidence is preclinical only (in vitro cell studies and rodent models). No controlled human clinical trials have been published establishing efficacy for inflammatory conditions in humans.

4.2 Anti-Allergic Activity

The prevalence of immune-mediated allergic disorders, including food allergies, atopic dermatitis, allergic asthma, and allergic rhinitis, is rising globally. In various allergic animal models, crude extracts from C. gladiata have been shown to exhibit antiallergic activity.

Researchers investigated the anti-allergic mechanism in a mouse model of ovalbumin-induced asthma. SBP treatment significantly reduced the infiltration of inflammatory cells and the release of histamine, immunoglobulin E, and leukotriene in serum and bronchoalveolar lavage fluid (BALF). SBP markedly suppressed the activation of the MAPK signaling pathway and the expression of key inflammatory proteins (e.g., TNF-α) and Th2 type cytokines (IL-5 and IL-13), and was effective in ameliorating allergic inflammation against ovalbumin-induced asthma by suppressing pulmonary inflammation.

In a separate investigation into food allergy, researchers studied the effect of seeds of C. gladiata extract (CGE) on the inhibition of allergic reactions using a cholera toxin and peanut extract–immunized food allergy mouse model, given that allergy to peanuts is a major cause of fatal food-induced anaphylaxis.

A further study on the mechanism of anti-allergic activity found that a 30% ethanol extract from fruits down-regulated PI3K, AKT, and mTOR mRNA expression, and reduced the release of β-hexosaminidase (Hexb) and histamine degranulation in rat RBL-2H3 mast cells triggered by anti-dinitrophenyl (anti-DNP) IgE.

Research on interleukin signaling identified further mechanisms: investigators discovered significant IL-33 inhibitory activity in the methanol extract of Canavalia gladiata pods; through chromatographic separation and LC-MS, they isolated 11 compounds, and assessed their inhibitory effects on IL-33/ST2 signaling in inflammatory and autoimmune processes; among them, compounds 7, 10, and 11 exhibited substantial IL-33 inhibitory efficacy, with values reaching 78%, 86%, and 79% at 100 µM, respectively.

Evidence strength: All available evidence is preclinical (cell-based and rodent models). The mechanistic data are detailed, but there are no published human clinical trials.

4.3 Anti-Obesity and Lipid Metabolism Effects

Several laboratory studies have examined the capacity of C. gladiata extracts to inhibit adipogenesis (fat cell formation) and lipogenesis (fat synthesis). One study investigated the effect of C. gladiata extract (CGE) on the regulation of AMP-activated protein kinase (AMPK) in 3T3-L1 preadipocytes; lipid accumulation and differentiation were suppressed by 1.1, 1.3, and 1.4 times under CGE treatment at 0.25, 0.5, and 1.0 mg/mL, respectively.

The extract at 1.0 mg/mL increased the mRNA expressions of AMPK and carnitine palmitoyl transferase-1 (CPT-1) by 1.9 and 1.2 times respectively, while it decreased the expression of SREBP-1c, PPARγ, C/EBPα, and FAS by 1.1, 1.2, 1.8, and 1.5 times respectively, indicating inhibition of adipogenesis and lipogenesis potential. Gallic acid (4.02 mg/g) was identified as the main component of the CGE via LC-MS/MS and HPLC analysis; the results of this study suggested that CGE can be utilized as an anti-obesity food additive or medication by activating AMPK-induced regulation and suppressing adipogenesis transcription factors.

A study using high-fat-diet mice found that immature sword bean pods (Canavalia gladiata) inhibit adipogenesis in C3H10T1/2 cells and mice with high-fat diet–induced obesity, as published in the Journal of the Chinese Medical Association (2022); SB is rich in nutrients, such as flavonoids and urease, and has various functions including anti-inflammatory and anti-oxidant activity.

Evidence strength: Evidence is exclusively preclinical (cell lines and rodent high-fat diet models). No human randomized controlled trials on weight management have been published.

4.4 Antimicrobial Activity

In folk medicine, C. gladiata has been employed to treat suppurative inflammatory conditions such as sinusitis, hemorrhoids, and boils; its anticancer and antidiabetic activities have also been reported. Laboratory studies have begun to characterize the antimicrobial mechanisms. Tetrapropylhexose had the most vigorous antibacterial activity among the gallotannin-rich fractions, which showed varied levels of antimicrobial activity against Gram-positive and Gram-negative bacteria; additionally, a 50% ethanol extract and canavanine were found to effectively reduce Porphyromonas gingivalis-induced alveolar bone resorption and prevent the growth of P. gingivalis and Fusobacterium nucleatum. C. gladiata has been used in traditional medicine to treat suppurative inflammatory conditions, and its antibacterial activity against oral pathogens and potential use as a non-alcoholic mouthwash have been reported.

Evidence strength: Preclinical in vitro data only. The potential for antimicrobial activity in vivo still requires investigation.

4.5 Antioxidant Activity

The development of many degenerative diseases, including cancer, heart disease, and immunological dysfunction, is linked to an overabundance of free radicals; antioxidants neutralize and scavenge free radicals from the body. Laboratory investigations have confirmed significant antioxidant activity in sword bean preparations. Due to their high phenolic content, the red and black seeds of C. gladiata exhibited greater antioxidant potential compared to white seeds; researchers found that an 80% methanol extract from red seed coatings exhibited high ferric-reducing antioxidant power.

Lab research confirms that sword beans contain bioactive substances such as canavanine, flavonoids, and phenolic acids that have antibacterial, anti-inflammatory, and antioxidant qualities.

Evidence strength: Primarily in vitro. No human clinical trials establishing clinically meaningful antioxidant benefit.

4.6 Antitumor and Anticancer Activity

The lectin isolated from Japanese red sword beans (Canavalia gladiata) has been studied as a potential cancer chemopreventive agent. RSB lectin shows specificity to mannose, glucose, maltose, and methyl-d-mannoside; it exhibits similarities to Concanavalin A, shows mitogenic activity for mouse splenic cells and strong antiproliferative activity for B16 melanoma cells, and enhances the activity of splenic natural killer (NK) cells against YAC-1 cells.

4-O-methylgallic acid isolated from the seed of Canavalia gladiata has been identified as a compound with potential antiangiogenic activity (Biochemical and Biophysical Research Communications, 2005).

Evidence strength: Preclinical only (cell lines). No human clinical trials for any cancer indication have been reported in the peer-reviewed literature.

4.7 Antidiabetic and Metabolic Activity

The plant contains several bioactive components, such as canavanine, gibberellin I, and gibberellin II, which are known to have antioxidant, antibacterial, and antidiabetic properties. Anticancer and antidiabetic activities of C. gladiata have been reported in the literature.

Evidence strength: Animal model and in vitro data only. The comprehensive 2025 review published in Drug Design, Development and Therapy (PMC) explicitly noted that in-depth studies including clinical research trials are still needed.

4.8 Immunomodulatory Activity

Crude extracts, fractions, and constituents from C. gladiata show immunomodulatory pharmacological activities. The lectins, particularly concanavalin A and related proteins present in the seeds, have established roles in modulating lymphocyte and NK cell activity in preclinical models, as detailed in the lectin and cancer sections above.

Evidence strength: Preclinical. Immunomodulatory effects observed primarily in murine cell and animal models.

5. Body Systems and Health Areas of Association

• Immune and Allergic System: Immune-mediated allergic conditions including atopic dermatitis, allergic asthma, and allergic rhinitis have been studied in animal models of C. gladiata extract.
• Gastrointestinal System: Traditional uses include reducing inflammation and treating digestive issues like nausea, vomiting, and chronic dysentery; sword bean extracts are used in ethnobotanical applications to promote digestive function.
• Respiratory System: SBP was shown to be effective in ameliorating allergic inflammation in an ovalbumin-induced asthma model; asthma is one of the most common chronic respiratory diseases affecting 300–400 million people worldwide.
• Metabolic/Adipose System: CGE was confirmed to inhibit triglyceride accumulation and preadipocyte differentiation through regulation of AMPK-inducing transcription factors; the results provide basic data supporting the use of C. gladiata as an anti-obesity functional food and pharmaceutical product.
• Oral/Dental Health: Sword bean extracts are used in ethnobotanical applications to improve dental health. Preclinical antimicrobial data support activity against oral pathogens.
• Dermatological Use: The sword bean is used in Korea for atopic dermatitis; a soap made with red sword bean extract is marketed for treating athlete's foot and acne.
• Oncology (Preclinical Only): RSB lectin shows antiproliferative activity against B16 melanoma cells and NK cell-enhancing activity in vitro.

6. Forms, Preparations, and Dosages Reported in Studies

Plant Parts Used

The seeds and pods are the primary parts used, but they require thorough processing. Seeds contain bioactive compounds but also antinutritional factors and must be cooked. Young pods are consumed as a vegetable after proper preparation.

Preparation Forms

• Ethanol extracts (30–80%) are the most common research preparations used in published laboratory studies, extracted from seeds, pods, or seed coats.
• Methanol extracts of pods have been used in IL-33 inhibition research.
• Water-based decoctions of seeds are the classical TCM preparation form, as described in the Chinese Materia Medica.
• Pickled pods (Fukujin-zuke, Nuka-zuke, Miso-zuke) are consumed as traditional food preparations in Japan.
• Coffee substitute preparations from roasted seeds are documented in Korea and Japan.
• Topical soap formulations based on red sword bean extract are sold commercially in Korea.

Dosages Reported in Scientific Studies

In a 3T3-L1 preadipocyte study, CGE (Canavalia gladiata extract) was tested at concentrations of 0.25, 0.5, and 1.0 mg/mL, with lipid accumulation and differentiation suppressed by 1.1, 1.3, and 1.4 times respectively across the dosage range.

In a study examining IL-33 inhibitory activity from pod compounds, the three most active compounds (7, 10, and 11) exhibited inhibitory efficacy of 78%, 86%, and 79% at 100 µM respectively.

No validated human dosage ranges from clinical trials have been established for Canavalia gladiata in any therapeutic indication, as human trials have not been published.

7. Safety Considerations and Toxicology

Antinutritional Factors and Inherent Toxicity

The immature seeds of C. gladiata are a popular vegetable but contain hydrogen cyanide, canavanine, and lectins, which can lead to food poisoning if consumed raw or improperly processed. Ripe seeds contain antinutritional substances including canavanine, urease, concanavalin A and B, and canavalin; ripe seeds are not considered a primary commercial product, and overconsumption results in nausea and tiredness.

In China, two poisoning incidents due to consumption of undercooked immature seeds occurred in 2019 and 2021 respectively. The predominant toxic symptoms were nausea, dizziness, vomiting, abdominal pain, headache, panic, weakness, diarrhea, acid reflux, and a burning sensation in the stomach.

Processing Requirements for Safe Consumption

The ripe seeds are poisonous, and overconsumption results in nausea and tiredness. It is possible but time-consuming to detoxify by altering the cooking water, soaking, rinsing, or fermenting. Mature seeds of C. gladiata require detoxification through dehulling, soaking in salted water, multiple boiling changes, or fermentation before consumption.

Canavanine-Specific Toxicity

Canavanine is a non-protein amino acid analog of arginine that can be toxic if ingested in large quantities, interfering with cellular metabolism. As a structural arginine analog, canavanine can be mistakenly incorporated into proteins during biosynthesis, disrupting protein function. This mechanism is well-documented for the related species Canavalia ensiformis and applies similarly to C. gladiata.

Batch Variability and Standardization Issues

The secondary metabolites of C. gladiata are susceptible to seasonal, climatic, and geographic influences, resulting in significant variations in the pharmacological activities of extracts from different batches. This raises important considerations for any standardized supplement use, as the same preparation approach may yield varying concentrations of bioactive compounds.

Overall Evidence Status and Research Gaps

More in-depth studies including chemical composition, pharmacological mechanism, quality standardization, toxicology, and clinical research trials are needed for C. gladiata as a new candidate for future drug development. Depth studies of its main compounds should be confirmed regarding their safety and bioavailability; pharmacokinetic and pharmacodynamic studies should be conducted to determine efficacy and identify further medicinal applications.

8. Summary of Evidence Quality

The totality of published evidence for Canavalia gladiata as a dietary supplement or medicinal ingredient is currently preclinical. The plant and its bioactive compounds possess outstanding pharmacological properties including hemagglutinating activity, HIV-I inhibition, antimicrobial, antiproliferative, hepatoprotective, ROS-inhibition, anticancer, and antidiabetic effects that have been studied; chemical constituents, pharmacological activities, and clinical studies show a promising medicinal plant with various chemical compounds and numerous pharmacological activities. However, every area of pharmacological investigation reviewed — anti-inflammatory, anti-allergic, anti-obesity, antimicrobial, antidiabetic, antitumor, and immunomodulatory — is based on in vitro cell-based work and rodent animal models. No peer-reviewed, controlled human clinical trials have been published for any specific health indication as of the most recent comprehensive review (PMC 2025). More in-depth studies including chemical composition, pharmacological mechanism, quality standardisation, toxicology, and clinical research trials are needed for C. gladiata as a new candidate for future drug development.

References

• Qian H et al. "Ethnobotanical Use, Phytochemistry, Pharmacology, and Toxicity of Canavalia gladiata." Drug Design, Development and Therapy (2025). PMC12075509.
• Qian H et al. "Ethnobotanical Use, Phytochemistry, Pharmacology, and Toxicity of Canavalia gladiata." Dove Medical Press – Drug Design, Development and Therapy (full article, 2025).
• Wikipedia. "Canavalia gladiata." Wikimedia Foundation.
• Huang Y et al. "Sword Bean (Canavalia gladiata) Pod Exerts Anti-Allergic and Anti-Inflammatory Effects through Modulation of Th1/Th2 Cell Differentiation." Nutrients 14(14):2853 (2022). PMC9322724.
• Park JU et al. "Canavalia gladiata Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK." PMC9573573 (2022).
• Hong JW et al. "Inhibition Effect of Adipogenesis and Lipogenesis via Activation of AMPK in Preadipocytes Treated with Canavalia gladiata Extract." Int J Mol Sci. 24(3):2108 (2023). PMC9916869.
• Hong JW et al. "Inhibition Effect of Adipogenesis and Lipogenesis via Activation of AMPK in Preadipocytes Treated with Canavalia gladiata Extract." PubMed 36768430.
• Identification of Interleukin (IL)-33 Inhibitory Constituents from Canavalia gladiata Pods. PMC11273637.
• Gan RY et al. "Separation, Identification, and Bioactivities of the Main Gallotannins of Red Sword Bean (Canavalia gladiata) Coats." Front Chem. 6:39 (2018). PMID: 29541634.
• Inhibitory Effect of Canavalia gladiata Extract on Aggregatibacter actinomycetemcomitans LPS Induced Nitric Oxide in Macrophages. PMC12694063.
• The Pharmacological and Therapeutic Activities of Canavalia gladiata (Jacq.) DC. ResearchGate.
• Ekanayake S, Skog K, Asp NG. "Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing." ResearchGate.
• Anti-inflammatory Effects of Canavaliae Semen (Canavalia gladiata) Extracts in a Systemic Anaphylaxis Food Allergy Mouse Model. Korea Journal of Herbology.
• Feedipedia. "Sword bean (Canavalia gladiata)." FAO/INRA/CIRAD/AFZ.
• Origin, Distribution, Cytogenetics of Canavalia gladiata. Journal of Critical Reviews in Agriculture (2024).
• Plants of the World Online. "Canavalia gladiata (Jacq.) DC." Royal Botanic Gardens, Kew.
• "A Phytochemical Screening of Canavalia Gladiata (Sword Bean): A Comprehensive Pharmacognostic and Phytochemical Study." World Journal of Biology, Pharmacy and Health Sciences (2025).
• Useful Tropical Plants Database. "Canavalia gladiata." The Ferns.
• Easy Ayurveda. "Sword Bean – Medicinal Qualities, Toxicity, Research." (2020).